Amgen Czech Republic made a net profit of CZK 37.8 mil in 2017, up 20% compared to the previous year. Historically, between 2005 and 2017, the company's net profit reached a high of CZK 46.2 mil in 2011 and a low of CZK 5.00 mil in 2005.
The result implies a return on equity of 18.6% and a return on invested capital of 14.2% in 2017. That is compared to an average of 18.1% and 29.5% over the last five years.
The company has been operating with average EBITDA margin of 8.59% in the last 5 years and an average net margin of 6.51%.
Since 2012, the firm's net profit increased by 33.4% or an average of 5.94% a year.
You can see all the company’s data at Amgen Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
